Showing results (1291-1300 of 9,006) with videos related to

Sort By:
Pageof 901
European Journal of Clinical Pharmacology|January 1, 1985
Interaction of diazepam or lorazepam with alcohol. Psychomotor effects and bioassayed serum levels after single and repeated dosesK Aranko, T Seppälä, J Pellinen, et al.
European Journal of Clinical Pharmacology|January 2, 2021
The influence of recipient SLCO1B1 rs2291075 polymorphism on tacrolimus dose-corrected trough concentration in the early period after liver transplantationYi Wu, Fang Fang, Zhaowen Wang, et al.
European Journal of Clinical Pharmacology|January 1, 1986
Systolic time intervals in evaluation of the negative inotropic effect after single oral doses of mexiletine and disopyramideD Rousson, C Piolat, J Galleyrand, et al.
European Journal of Clinical Pharmacology|January 1, 1986
The effect of acetaminophen administration on its disposition and body stores of sulphateS Hendrix-Treacy, S M Wallace, K W Hindmarsh, et al.
European Journal of Clinical Pharmacology|January 1, 1986
Pharmacokinetics of intravenous and intraperitoneal moxalactam in chronic ambulatory peritoneal dialysisH Albin, J M Ragnaud, F Demotes-Mainard, et al.
European Journal of Clinical Pharmacology|January 1, 1986
Methods of comparing pharmacokinetics of slow release preparations: a comparison of "Theo-Dur" and "Phyllocontin" in patients with asthmaS H Jackson, K Shah, P Turner
European Journal of Clinical Pharmacology|January 1, 1986
Effect of halothane anaesthesia on salivary elimination of paracetamolK Ray, C Adithan, J S Bapna, et al.
European Journal of Clinical Pharmacology|July 30, 2021
The pharmacokinetic interaction between nasally administered naloxone and the opioid remifentanil in human volunteersIda Tylleskar, Sissel Skarra, Arne Kristian Skulberg, et al.
European Journal of Clinical Pharmacology|July 28, 2021
Unintentional guideline deviations in hospitalized patients with two or more antithrombotic agents: an intervention studyRenate C A E van Uden, Marcel P H van den Broek, Ilse Houtenbos, et al.
European Journal of Clinical Pharmacology|April 17, 2013
Low allopurinol doses are sufficient to optimize azathioprine therapy in inflammatory bowel disease patients with inadequate thiopurine metabolite concentrationsIvanka Curkovic, Katharina M Rentsch, Pascal Frei, et al.
Pageof 901